secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001104659-24-071796
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Carisma Therapeutics holds annual meeting; all proposals approved by shareholders
--------------------------------------------------------------------------------

- Directors John Hohneker, M.D. and Michael Torok elected with 16.7M and 16.0M votes for respectively.
- Non-binding advisory say-on-pay proposal approved: 16.7M for, 575K against, 60K abstain.
- Ratification of KPMG LLP as independent auditor for FY2024 approved: 24.4M for, 173K against.
- Meeting adjourned from June 13 due to technical difficulties; reconvened and completed June 14.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465924071796/0001104659-24-071796-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465924071796/tm2417340d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-071796

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer